Rajesh Shah | |
---|---|
Nationality | India |
Occupation | Homeopath |
Website | https://www.askdrshah.com/ |
Rajesh Shah (born January 18, 1963) is a practicing in Mumbai, India. He was one of the first to start online medical practice in India in 1995. He is also awarded with Limca Book of Records for his medical developments for Swine Flu.
He has conducted clinical trials using conventional research methods for HIV and Hepatitis C, using the respective nosodes, and concluded that high dilution, potentised homeopathic preparation from HIV virus could increase CD4 cells and reduce viral load in the responder group.
In the Homeopathic Pathogenetic Trial of the alkaloids Capsaicin and Dihydrocapsaicin, the interesting finding was that about 40% of the healthy volunteers produced symptoms pertaining to pain, with high-dilution, potentised medicine from the source materials which has known capacity to produce pain in crude form.
He has revamped the method of preparation and introduced a new nosode sourced from Mycobacterium Tuberculosis. This study prepared a nosode at the Haffkine Institute, sourced from four strains of the organisms, including Multidrug resistance Tuberculosis.
The nosode sourced from Hepatitis C virus produced anti-cancer effect on cell lines in a laboratory model. The research demonstrated that a nosode showed anti-cancer effect. By using advanced imaging techniques, research showed that the drug triggered the death of cancer cells through apoptosis, a process of controlled cell death, by decreasing two cancer related enzymes called telomerase and topoisomerase II in the liver cells.
Rajesh Shah is Secretary of the Global Homeopathy Foundation, an NGO working for the promotion of homeopathy.
He identified the need for a change in regulation in India in the Nosode category, responsible for lack of scientific research for new drug discovery. For getting the required regulation updated, and for creating awareness among the homeopaths, he initiated a petition to the Minister of AYUSH (Govt of India) for corrective measures.
Preclinical evaluation of anti-arthritic activity of ultra-diluted preparations of capsaicin alkaloids (CP-10), tumor necrosis factor-α, and Magnesium phosphoricum was conducted on Wistar rats which concluded that ultra-diluted preparations exhibited definite anti-arthritic activity, demonstrated in his research at leading institution.